A new report was presented in Vienna by the United Nations Office on Drugs and Crime together with the World Health Organization. The analysis focused on medicines circulating within the CEMAC region of Central Africa. Laboratory testing indicated that roughly 71 percent of the sampled pharmaceutical products were counterfeit. Such a high proportion of falsified drugs constitutes a serious public‑health danger. The findings have prompted authorities in the region to consider or undertake measures to address the problem.